期刊文献+

枸杞多糖对2型糖尿病大鼠周围神经病变的保护作用 被引量:12

Protective effect of lycium barbarum polysaccharides on peripheral neuropathy in type 2 diabetic rats
原文传递
导出
摘要 目的探讨枸杞多糖对T2DM大鼠周围神经病变的保护作用及其机制。方法 SD大鼠制备成T2DM大鼠模型后,随机分为模型组、枸杞多糖小剂量组、大剂量组及α-硫辛酸对照组。治疗10周后检测各组坐骨神经的传导速度,并测该组织中丙二醛(MDA)及谷胱甘肽过氧化酶物(GSH-Px)含量,观察其超微结构。结果与模型组相比,枸杞多糖大剂量组能改善神经传导速度[(32.31±3.54)vs(27.11±5.99)m/s,P<0.05],降低坐骨神经组织中MDA水平[(1.80±1.03)vs(2.32±1.02)nmol/ml,P<0.05],提高GSH-Px水平[(107.44±16.03)vs(67.83±28.91)U/gprot,P<0.05]。模型组坐骨神经超微结构有明显的损伤反应,经枸杞多糖干预后病变程度减轻。结论枸杞多糖通过抗氧化应激,可以提高神经传导速度,并同时改善周围神经的结构和功能,具有保护周围神经病变的作用。 Objective To explore the protective effect of lycium barbarum polysaccharides (LBP) on peripheral neuropathy in type 2 diabetic rats and its mechanism. Methods SD rats with STZ-induced T2DM were randomly divided into the model group, LBP low- and high-dose groups, and α-lipoic acid group. The course of treatment lasted for 10 weeks. The conduction velocity of sciatic nerve of all groups was detected and the contents of MDA and GSH-Px in sciatic nerve were determined, and the changes in its ultrastructure were observed. Results Compared with the model group, the LBP high dose group accelerated the nerve conduction velocity [(32. 31±3.54) vs (27. 11±5. 99) m/s,P〈0. 05], attenuated the content of MDA in sciatic nerve [(1. 80+1.03) vs (2. 324-1.02) nmol/ml, P〈0. 05], and elevated the content of GSH-Px I-(107.44±16.03) vs (67. 83±28. 91) U/gprot, P〈0. 05]. There were obvious damage reactions in the ultrastructure of sciatic nerve in the model group. However, the pathological condition in sciatic nerve was alleviated after the intervention with LBP. Conclusion LBP accelerates damages of the nerve conduction velocity through anti-oxidative stress, at the same time, it ameliorates damages of the structure and function of peripheral nerves, thus protecting the type 2 diabetic rats with peripheral neuropathy.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第7期647-650,共4页 Chinese Journal of Diabetes
基金 2009年宁夏回族自治区自然科学基金项目(NZ09141)
关键词 枸杞多糖 糖尿病 2型 周围神经病变 大鼠 Lycium Barbarum Polysaccharides (LBP) Diabetes mellitus, type 2 Peripheral neuropathy Rats
  • 相关文献

参考文献7

  • 1Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive syrup-toms in persons with diabetic peripheral ne uropathy: a longitudinal study. Diabetologia, 2009, 52:1265-1273.
  • 2王晶,宋薇,黄璟,屈玉春.前列腺素E_1联合α硫辛酸治疗糖尿病周围神经病变的疗效[J].实用医学杂志,2007,23(9):1325-1326. 被引量:27
  • 3Dive D, Lievens I, Moonen G, et al. Diabetic peripheral neuropathy. Rev Med Liege, 2005, 60:490-497.
  • 4杨前勇,邹大进.糖尿病并发症治疗新策略:防护线粒体氧化损伤[J].医学综述,2007,13(24):1973-1975. 被引量:16
  • 5Tang J, Wingerchuk DM, Crum BA, et al. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neu-rologist, 2007, 13..164-167.
  • 6Wu H, Guo H, Zhao R. Effect of Lyeium barrbarum polysac-charides on the improvement of antioxidant ability and DNA damage in NIDDM rats. Yakugaku Zasshi, 2006, 126: 365-371.
  • 7Cameron NE, Cotter MA. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetie rats: interaction with oxidative stress and essential fatty add dysmetabolism. Diabetes Metab Res Rev, 2002, 18:315-323.

二级参考文献28

  • 1章晓燕,刘芳,贾伟平.α-硫辛酸与糖尿病周围神经病变[J].国外医学(内分泌学分册),2005,25(4):262-264. 被引量:146
  • 2李亚,方弟晋,高霞,田浩明,吴泰相.前列腺素E_1治疗糖尿病周围神经病变的系统评价[J].中国循证医学杂志,2006,6(6):404-415. 被引量:23
  • 3周琳,高方,薛耀明.依帕司他对2型糖尿病周围神经病变的临床疗效[J].实用医学杂志,2006,22(17):2043-2044. 被引量:11
  • 4Genuth S,Alberti K G,Bennett P,et al.Follow-up report on the diagnosis of diabetes mellitus.The expert committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,2003,26(11):3160.
  • 5Carlson L A,Olsson A G.Intravenous prostaglandin E in severe peripheral vascular disease[J].Lancet,1976,9(7886):810.
  • 6Boulton A J,Malik R A,Arezzo J C,et al.Diabetic somatic neuropathies[J].Diabetes Care,2004,27(6):1458.
  • 7Tankova T,Cherninkova S,Koev D.Treatment for diabetic mononeuropathy with a-lipoic acid[J].Int J Clin Pract,2005,59 (6):645.
  • 8Akahori H,Takamura T,Hayakawa T,et al.Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy:clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality[J].Diabetes Res Clin Pract,2004,64(3):153.
  • 9Brownlee M. The Pathobiology of Diabetic Complications: A Unifying Mechanism[J]. Diabetes, 2005,54(6) : 1615-1625.
  • 10Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes [ J ]. Diabetes, 2004, 53 (Suppl 1 ) : 110-118.

共引文献41

同被引文献173

引证文献12

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部